- Home
- PEPG vs MCR Comparison
PEPG vs MCR Comparison
Compare PEPG & MCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEPG
- MCR
- Stock Information
- Founded
- PEPG 2018
- MCR 1989
- Country
- PEPG United States
- MCR United States
- Employees
- PEPG N/A
- MCR N/A
- Industry
- PEPG Biotechnology: Pharmaceutical Preparations
- MCR Trusts Except Educational Religious and Charitable
- Sector
- PEPG Health Care
- MCR Finance
- Exchange
- PEPG Nasdaq
- MCR Nasdaq
- Market Cap
- PEPG 317.6M
- MCR 265.5M
- IPO Year
- PEPG 2022
- MCR N/A
- Fundamental
- Price
- PEPG $4.62
- MCR $6.36
- Analyst Decision
- PEPG Strong Buy
- MCR
- Analyst Count
- PEPG 6
- MCR 0
- Target Price
- PEPG $8.17
- MCR N/A
- AVG Volume (30 Days)
- PEPG 9.6M
- MCR 66.7K
- Earning Date
- PEPG 11-06-2025
- MCR 01-01-0001
- Dividend Yield
- PEPG N/A
- MCR 8.52%
- EPS Growth
- PEPG N/A
- MCR N/A
- EPS
- PEPG N/A
- MCR 0.38
- Revenue
- PEPG N/A
- MCR N/A
- Revenue This Year
- PEPG N/A
- MCR N/A
- Revenue Next Year
- PEPG N/A
- MCR N/A
- P/E Ratio
- PEPG N/A
- MCR $16.61
- Revenue Growth
- PEPG N/A
- MCR N/A
- 52 Week Low
- PEPG $0.88
- MCR $5.63
- 52 Week High
- PEPG $9.37
- MCR $6.70
- Technical
- Relative Strength Index (RSI)
- PEPG 63.02
- MCR 40.61
- Support Level
- PEPG $4.70
- MCR $6.36
- Resistance Level
- PEPG $5.20
- MCR $6.50
- Average True Range (ATR)
- PEPG 0.56
- MCR 0.07
- MACD
- PEPG 0.00
- MCR -0.01
- Stochastic Oscillator
- PEPG 59.00
- MCR 14.91
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
About MCR MFS Charter Income Trust
MFS Charter Income Trust is a United States-based closed-end fund. Its investment objective is to seek high current income, but may also consider capital appreciation. The fund invests the assets in Debt Instruments, Corporate Bonds, U.S. Government Securities, Foreign Government Securities, Securitized Instruments, Derivatives, Principal Risks, Debt Management Risk, Investment Selection Risk, Interest Rate Risk, Credit Risk, Foreign Risks, Emerging Markets Risk, Currency Risk, Leveraging Risk, Operational and Cybersecurity Risk, Active and Frequent Trading, and etc of different market countries.